These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8121250)

  • 1. Action of the new hypolipidemic agent lifibrol (K12.148) on lipid homeostasis in normal rats: plasma lipids, hepatic sterologenesis, and the fate of injected [14C]acetate.
    Bell FP; St John LC
    Lipids; 1993 Dec; 28(12):1079-85. PubMed ID: 8121250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lifibrol to other lipid-regulating agents in experimental animals.
    Krause BR; Bousley R; Kieft K; Robertson D; Stanfield R; Urda E; Newton RS
    Pharmacol Res; 1994; 29(4):345-57. PubMed ID: 7971686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the lipid-lowering drug lifibrol on lipid metabolism in rat macrophages and in atherosclerotic arteries from swine and WHHL rabbits, in vitro. Implications in atherogenesis.
    Bell FP
    Biochem Pharmacol; 1993 Oct; 46(8):1475-80. PubMed ID: 8240398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway.
    Scharnagl H; Schliack M; Löser R; Nauck M; Gierens H; Jeck N; Wieland H; Gross W; März W
    Atherosclerosis; 2000 Nov; 153(1):69-80. PubMed ID: 11058701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
    Berthold HK; Sudhop T; von Bergmann K; Gouni-Berthold I
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):364-72. PubMed ID: 20693157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lifibrol on the metabolism of low density lipoproteins and cholesterol.
    Vega GL; von Bergmann K; Grundy SM; Blumenschein S; Carter NB; Laeis P; Lindenthal B; von Bergmann J; Simatupang A; Lutjohann D; Adams-Huet B
    J Intern Med; 1999 Jul; 246(1):1-9. PubMed ID: 10447220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats.
    Okada K; Yagasaki K; Mochizuki T; Takagi K; Irikura T
    Biochem Pharmacol; 1985 Sep; 34(18):3361-7. PubMed ID: 4038342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of acyl CoA: cholesterol acyltransferase and sterologenesis in rat liver by diazepam, in vitro.
    Bell FP
    Lipids; 1985 Feb; 20(2):75-9. PubMed ID: 3982236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of N-(4-methylbenzylthiocarbonyl)-L-phenylalanine (KF 1492), a new phenylalanine derivative on lipid synthesis in vivo, inhibition of hepatic cholesterol synthesis and 3-hydroxy-3-methylglutaryl-Co A reductase.
    Ishii A; Deguchi T; Marumo H; Tanaka M
    J Pharmacobiodyn; 1981 Dec; 4(12):933-9. PubMed ID: 7341749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of portacaval shunt on plasma lipids and tissue cholesterol synthesis in the dog.
    Coyle JJ; Schwartz MZ; Marubbio AT; Varco RL; Buchwald H
    Surgery; 1976 Jul; 80(1):54-60. PubMed ID: 179161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteers.
    Hasibeder H; Staab HJ; Seibel K; Heibel B; Schmidle G; März W
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S91-4. PubMed ID: 2044652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-carnitine administration and withdrawal affect plasma and hepatic carnitine concentrations, plasma lipid and lipoprotein composition, and in vitro hepatic lipogenesis from labeled mevalonate and oleate in normal rabbits.
    Bell FP; Vidmar TJ; Raymond TL
    J Nutr; 1992 Apr; 122(4):959-66. PubMed ID: 1552371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of protocatechuic acid on lipid profile and DNA damage in D-galactosamine-induced hepatotoxic rats.
    Radhiga T; Sundaresan A; Viswanathan P; Pugalendi KV
    J Basic Clin Physiol Pharmacol; 2016 Sep; 27(5):505-14. PubMed ID: 27226100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia.
    Winkler K; Schaefer JR; Klima B; Nuber C; Friedrich I; Köster W; Gierens H; Scharnagl H; Soufi M; Wieland H; März W
    Atherosclerosis; 2000 May; 150(1):113-20. PubMed ID: 10781641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic effects of synthetic gugulsterones in normal rats and assessment of its long-term toxicity at cellular levels in various organs.
    Far SR; Master HE; Billimoria FR; Sane RT
    Indian J Med Sci; 1996 Mar; 50(3):63-7. PubMed ID: 8979620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olive oils improve lipid metabolism and increase antioxidant potential in rats fed diets containing cholesterol.
    Gorinstein S; Leontowicz H; Lojek A; Leontowicz M; Ciz M; Krzeminski R; Gralak M; Czerwinski J; Jastrzebski Z; Trakhtenberg S; Grigelmo-Miguel N; Soliva-Fortuny R; Martin-Belloso O
    J Agric Food Chem; 2002 Oct; 50(21):6102-8. PubMed ID: 12358487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bezafibrate treatment on the altered lipoprotein profiles in hypertriglyceridemic subjects.
    Norioka M; Suzuki M; Ryomoto K; Ikebuchi M; Harano Y
    J Atheroscler Thromb; 2000; 7(4):198-202. PubMed ID: 11521682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of lifibrol (U-83860) to mixed glyceride metabolites by rat and human hepatocytes in primary culture.
    Sun EL; Feenstra KL; Bell FP; Sanders PE; Slatter JG; Ulrich RG
    Drug Metab Dispos; 1996 Feb; 24(2):221-31. PubMed ID: 8742235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 780 SE on lipid metabolism in rabbit aorta.
    Marquie G
    Eur J Pharmacol; 1977 Sep; 45(1):1-6. PubMed ID: 891614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia.
    Winkler K; Schäfer JR; Klima B; Nuber C; Sattler A; Friedrich I; Köster W; Steinmetz A; Wieland H; März W
    Atherosclerosis; 1999 May; 144(1):167-75. PubMed ID: 10381290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.